Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 275

1.

Gamma irradiation during gametogenesis in young adult zebrafish causes persistent genotoxicity and adverse reproductive effects.

Hurem S, Gomes T, Brede DA, Mayer I, Lobert VH, Mutoloki S, Gutzkow KB, Teien HC, Oughton D, Aleström P, Lyche JL.

Ecotoxicol Environ Saf. 2018 Feb 13;154:19-26. doi: 10.1016/j.ecoenv.2018.02.031. [Epub ahead of print]

PMID:
29453161
2.

HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

Hyman DM, Piha-Paul SA, Won H, Rodon J, Saura C, Shapiro GI, Juric D, Quinn DI, Moreno V, Doger B, Mayer IA, Boni V, Calvo E, Loi S, Lockhart AC, Erinjeri JP, Scaltriti M, Ulaner GA, Patel J, Tang J, Beer H, Selcuklu SD, Hanrahan AJ, Bouvier N, Melcer M, Murali R, Schram AM, Smyth LM, Jhaveri K, Li BT, Drilon A, Harding JJ, Iyer G, Taylor BS, Berger MF, Cutler RE Jr, Xu F, Butturini A, Eli LD, Mann G, Farrell C, Lalani AS, Bryce RP, Arteaga CL, Meric-Bernstam F, Baselga J, Solit DB.

Nature. 2018 Feb 8;554(7691):189-194. doi: 10.1038/nature25475. Epub 2018 Jan 31.

PMID:
29420467
3.

Motor cortex synchronization influences the rhythm of motor performance in premanifest huntington's disease.

Casula EP, Mayer IMS, Desikan M, Tabrizi SJ, Rothwell JC, Orth M.

Mov Disord. 2018 Jan 22. doi: 10.1002/mds.27285. [Epub ahead of print]

PMID:
29356133
4.

MCP-1, KC-like and IL-8 as critical mediators of pathogenesis caused by Babesia canis.

Galán A, Mayer I, Rafaj RB, Bendelja K, Sušić V, Cerón JJ, Mrljak V.

PLoS One. 2018 Jan 5;13(1):e0190474. doi: 10.1371/journal.pone.0190474. eCollection 2018.

5.

PIK3CA C2 domain deletions hyperactivate phosphoinositide 3-kinase (PI3K), generate oncogene dependence and are exquisitely sensitive to PI3Kα inhibitors.

Croessmann S, Sheehan JH, Lee KM, Sliwoski GR, He J, Nagy RJ, Riddle DA, Mayer IA, Balko JM, Lanman RB, Miller V, Cantley LC, Meiler J, Arteaga CL.

Clin Cancer Res. 2017 Dec 28. pii: clincanres.2141.2017. doi: 10.1158/1078-0432.CCR-17-2141. [Epub ahead of print]

PMID:
29284706
6.

Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.

Pulley JM, Jerome RN, Ogletree ML, Bernard GR, Lavieri RR, Zaleski NM, Hong CC, Shirey-Rice JK, Arteaga CL, Mayer IA, Holroyd KJ, Cook RS.

Target Oncol. 2017 Dec 7. doi: 10.1007/s11523-017-0542-1. [Epub ahead of print] Review.

PMID:
29218624
7.

Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.

McColgan P, Gregory S, Seunarine KK, Razi A, Papoutsi M, Johnson E, Durr A, Roos RAC, Leavitt BR, Holmans P, Scahill RI, Clark CA, Rees G, Tabrizi SJ; Track-On HD Investigators.

Biol Psychiatry. 2018 Mar 1;83(5):456-465. doi: 10.1016/j.biopsych.2017.10.019. Epub 2017 Oct 26.

8.

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.

Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group.

Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13.

PMID:
29146401
9.

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.

Rimawi MF, De Angelis C, Contreras A, Pareja F, Geyer FC, Burke KA, Herrera S, Wang T, Mayer IA, Forero A, Nanda R, Goetz MP, Chang JC, Krop IE, Wolff AC, Pavlick AC, Fuqua SAW, Gutierrez C, Hilsenbeck SG, Li MM, Weigelt B, Reis-Filho JS, Kent Osborne C, Schiff R.

Breast Cancer Res Treat. 2018 Feb;167(3):731-740. doi: 10.1007/s10549-017-4533-9. Epub 2017 Nov 7.

PMID:
29110152
10.

Endoscopic Retrograde Cholangiopancreatography in Nonagenarian Patients: Is It Really Safe?

Sobani ZA, Yunina D, Abbasi A, Tin K, Simkin D, Rojas M, Tsirlin Y, Mayer I, Rahmani R.

Clin Endosc. 2017 Sep 18. doi: 10.5946/ce.2017.123. [Epub ahead of print]

11.

Reproduction biotechnologies in germplasm banking of livestock species: a review.

Morrell JM, Mayer I.

Zygote. 2017 Oct;25(5):545-557. doi: 10.1017/S0967199417000442. Epub 2017 Aug 24.

PMID:
28835292
12.

Conceptual Problem with Calculating Electron Densities in Finite Basis Density Functional Theory.

Mayer I, Pápai I, Bakó I, Nagy Á.

J Chem Theory Comput. 2017 Sep 12;13(9):3961-3963. doi: 10.1021/acs.jctc.7b00562. Epub 2017 Aug 25.

PMID:
28834682
13.

The reliability of commonly used electrophysiology measures.

Brown KE, Lohse KR, Mayer IMS, Strigaro G, Desikan M, Casula EP, Meunier S, Popa T, Lamy JC, Odish O, Leavitt BR, Durr A, Roos RAC, Tabrizi SJ, Rothwell JC, Boyd LA, Orth M.

Brain Stimul. 2017 Nov - Dec;10(6):1102-1111. doi: 10.1016/j.brs.2017.07.011. Epub 2017 Jul 31.

PMID:
28807846
14.

Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance.

Giltnane JM, Hutchinson KE, Stricker TP, Formisano L, Young CD, Estrada MV, Nixon MJ, Du L, Sanchez V, Ericsson PG, Kuba MG, Sanders ME, Mu XJ, Van Allen EM, Wagle N, Mayer IA, Abramson V, Gόmez H, Rizzo M, Toy W, Chandarlapaty S, Mayer EL, Christiansen J, Murphy D, Fitzgerald K, Wang K, Ross JS, Miller VA, Stephens PJ, Yelensky R, Garraway L, Shyr Y, Meszoely I, Balko JM, Arteaga CL.

Sci Transl Med. 2017 Aug 9;9(402). pii: eaai7993. doi: 10.1126/scitranslmed.aai7993.

15.

Hormonal changes over the spawning cycle in the female three-spined stickleback, Gasterosteus aculeatus.

Roufidou C, Schmitz M, Mayer I, Sebire M, Katsiadaki I, Shao YT, Borg B.

Gen Comp Endocrinol. 2018 Feb 1;257:97-105. doi: 10.1016/j.ygcen.2017.07.030. Epub 2017 Aug 2.

PMID:
28779857
16.

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.

Formisano L, Stauffer KM, Young CD, Bhola NE, Guerrero-Zotano AL, Jansen VM, Estrada MM, Hutchinson KE, Giltnane JM, Schwarz LJ, Lu Y, Balko JM, Deas O, Cairo S, Judde JG, Mayer IA, Sanders M, Dugger TC, Bianco R, Stricker T, Arteaga CL.

Clin Cancer Res. 2017 Oct 15;23(20):6138-6150. doi: 10.1158/1078-0432.CCR-17-1232. Epub 2017 Jul 27.

PMID:
28751448
17.

Safety of Percutaneous Endoscopic Gastrostomy Tubes in Centenarian Patients.

Sobani ZA, Tin K, Guttmann S, Abbasi AA, Mayer I, Tsirlin Y.

Clin Endosc. 2018 Jan;51(1):56-60. doi: 10.5946/ce.2017.059. Epub 2017 Jul 21.

18.

Dietary l-tryptophan leaves a lasting impression on the brain and the stress response.

Höglund E, Øverli Ø, Andersson MÅ, Silva P, Laursen DC, Moltesen MM, Krogdahl Å, Schjolden J, Winberg S, Vindas MA, Mayer I, Hillestad M.

Br J Nutr. 2017 May;117(10):1351-1357. doi: 10.1017/S0007114517001428. Epub 2017 Jun 19.

PMID:
28625179
19.

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators.

N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. Erratum in: N Engl J Med. 2017 Aug 17;377(7):702.

20.

Novel Targeted Agents and Immunotherapy in Breast Cancer.

Mayer IA, Dent R, Tan T, Savas P, Loi S.

Am Soc Clin Oncol Educ Book. 2017;37:65-75. doi: 10.14694/EDBK_175631.

Supplemental Content

Loading ...
Support Center